| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.8M | — | -34.5% |
| Cost of Revenue | $12.6M | — | -39.5% |
| Gross Profit | $1.2M | — | +493.5% |
| R&D Expense | $513K | — | +397.6% |
| SG&A Expense | $551K | — | -51.2% |
| Operating Income | -$289K | — | +85.8% |
| Interest Expense | $28K | — | +2788.5% |
| Pre-tax Income | -$201K | — | +89.8% |
| Net Income | -$201K | — | +89.8% |
| EPS (Basic) | -$0.02 | — | +95.9% |
| EPS (Diluted) | -$0.02 | — | +95.9% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $1.2M | -14.7% | +6253.6% |
| Inventory | $201K | -2.9% | -3.6% |
| Current Assets | $2.7M | -7.0% | -62.2% |
| Total Assets | $7.7M | +14.2% | -3.3% |
| Current Liabilities | $4.1M | +12.6% | +8.6% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $879K | — | +220.0% |
| Capital Expenditures | $3K | — | +0.0% |
| Investing Cash Flow | -$1.6M | — | -3163.9% |
| Financing Cash Flow | $792K | — | -46.9% |
| Free Cash Flow | $877K | — | +219.2% |
| $4.7M |
| +23.3% |
| +20.2% |
| Stockholders' Equity | $3.0M | +2.4% | -26.3% |